NeuPath Health Inc.

TSXV:NPTH Stock Report

Market Cap: CA$10.7m

NeuPath Health Management

Management criteria checks 2/4

NeuPath Health's CEO is Joe Walewicz, appointed in Sep 2022, has a tenure of 2.25 years. total yearly compensation is CA$576.57K, comprised of 56.4% salary and 43.6% bonuses, including company stock and options. directly owns 0.93% of the company’s shares, worth CA$99.22K. The average tenure of the management team and the board of directors is 3.4 years and 4.5 years respectively.

Key information

Joe Walewicz

Chief executive officer

CA$576.6k

Total compensation

CEO salary percentage56.4%
CEO tenure2.3yrs
CEO ownership0.9%
Management average tenure3.4yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Aug 18
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16
These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Apr 23
The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01
Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Dec 20
Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Aug 19
Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

CEO Compensation Analysis

How has Joe Walewicz's remuneration changed compared to NeuPath Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$852k

Jun 30 2024n/an/a

-CA$74k

Mar 31 2024n/an/a

-CA$293k

Dec 31 2023CA$577kCA$325k

-CA$107k

Sep 30 2023n/an/a

-CA$2m

Jun 30 2023n/an/a

-CA$3m

Mar 31 2023n/an/a

-CA$3m

Dec 31 2022CA$395kCA$117k

-CA$4m

Sep 30 2022n/an/a

-CA$3m

Jun 30 2022n/an/a

-CA$3m

Mar 31 2022n/an/a

-CA$3m

Dec 31 2021CA$38kn/a

-CA$3m

Sep 30 2021n/an/a

-CA$3m

Jun 30 2021n/an/a

-CA$3m

Mar 31 2021n/an/a

-CA$5m

Dec 31 2020CA$32kn/a

-CA$5m

Compensation vs Market: Joe's total compensation ($USD400.82K) is above average for companies of similar size in the Canadian market ($USD164.06K).

Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.

CEO

Joe Walewicz (55 yo)

2.3yrs

Tenure

CA$576,570

Compensation

Mr. Joseph Andrew Walewicz, also known as Joe, MBA, CFA, CLP served as Interim CEO at NeuPath Health Inc. since September 30, 2022 and has been its Director since June 25, 2020. He serves as Chief Executiv...

Leadership Team

NamePositionTenureCompensationOwnership
Joseph Walewicz
CEO & Director2.3yrsCA$576.57k0.93%
CA$ 99.2k
Jeff Zygouras
CFO & Corporate Secretary3.4yrsCA$488.18k0.11%
CA$ 11.4k
Bjorn Thies
Vice President of People & Culture3.7yrsno datano data

3.4yrs

Average Tenure

Experienced Management: NPTH's management team is considered experienced (3.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Joseph Walewicz
CEO & Director4.5yrsCA$576.57k0.93%
CA$ 99.2k
Daniel Chicoine
Independent Chair4.5yrsCA$113.12k0.17%
CA$ 18.7k
Daniel Legault
Independent Director5.7yrsCA$58.12k0.22%
CA$ 23.4k
Jolyon Burton
Independent Director4.5yrsno datano data
Sasha Cucuz
Independent Director4.5yrsCA$64.12k0.094%
CA$ 10.1k

4.5yrs

Average Tenure

55yo

Average Age

Experienced Board: NPTH's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 06:22
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NeuPath Health Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin KeywoodStifel Canada